Tempest Therapeutics Inc. (NASDAQ: TPST)
$0.9301
+0.0246 ( +2.77% ) 804.7K
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
Market Data
Open
$0.9301
Previous close
$0.9055
Volume
804.7K
Market cap
$41.46M
Day range
$0.8940 - $0.9750
52 week range
$0.8000 - $6.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 56 | Nov 12, 2024 |
| def | Proxies and info statements | 4 | Nov 12, 2024 |
| 8-k | 8K-related | 13 | Nov 12, 2024 |
| pre | Proxies and info statements | 4 | Oct 29, 2024 |
| 8-k | 8K-related | 17 | Oct 10, 2024 |
| 4 | Insider transactions | 1 | Aug 12, 2024 |
| 8-k | 8K-related | 13 | Aug 08, 2024 |
| 10-q | Quarterly Reports | 56 | Aug 08, 2024 |
| 4 | Insider transactions | 1 | Jul 08, 2024 |
| 4 | Insider transactions | 1 | Jul 03, 2024 |